Leukemia-associated phenotypes and their distribution at diagnosis
Aberrant phenotype . | Frequency (%)* . |
---|---|
CD34+CD56+ | 2 |
CD34+CD14+ | 5 |
CD34+CD11b+ | 46 |
CD34+CD49b+ | 2 |
CD34+CD69+ | 10 |
CD34+Icam+ | 15 |
C-kit+CD56+ | 6 |
CD33+CD2+ | 6 |
CD33+CD4+ | 15 |
CD33+CD7+ | 51 |
CD34+CD15+Hla-Dr+ | 11 |
CD34+CD33+CD7+ | 47 |
CD34+CD33+CD19+ | 5 |
CD34+CD33+CD4+ | 8 |
CD33−CD14+Hla-Dr+ | 17 |
CD33−CD15+Hla-Dr+ | 19 |
CD34+CD11b+C-kit+ | 47 |
CD34+C-kit+CD56+ | 1 |
Aberrant phenotype . | Frequency (%)* . |
---|---|
CD34+CD56+ | 2 |
CD34+CD14+ | 5 |
CD34+CD11b+ | 46 |
CD34+CD49b+ | 2 |
CD34+CD69+ | 10 |
CD34+Icam+ | 15 |
C-kit+CD56+ | 6 |
CD33+CD2+ | 6 |
CD33+CD4+ | 15 |
CD33+CD7+ | 51 |
CD34+CD15+Hla-Dr+ | 11 |
CD34+CD33+CD7+ | 47 |
CD34+CD33+CD19+ | 5 |
CD34+CD33+CD4+ | 8 |
CD33−CD14+Hla-Dr+ | 17 |
CD33−CD15+Hla-Dr+ | 19 |
CD34+CD11b+C-kit+ | 47 |
CD34+C-kit+CD56+ | 1 |
At least 2 aberrant phenotypes were observed for each case.